TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
R$99.50
0.00%
(0.00) 1D
Oct 16, 3:41:06 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TAKP34...
Mkt. cap
63.00B
Avg. vol.
37.00
Volume
0.00
52-wk high
R$102.65
52-wk low
R$70.80
Shares outstanding
1.60B
No. of employees
47K
Mkt. cap
63.00B
Avg. vol.
37.00
Volume
0.00
52-wk high
R$102.65
52-wk low
R$70.80
Shares outstanding
1.60B
No. of employees
47K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Takeda stock: Results are due October 29, 2026 for Takeda stock
ad-hoc-news.de
·
7 hours ago
Takeda reports positive TAK-881 data for Takeda Pharmaceutical stock
ad-hoc-news.de
·
10 hours ago
TAK stock sets October 29 results date ahead of the Xetra open
ad-hoc-news.de
·
2 days ago
Takeda schedules October 29 results as TAK stock awaits an update
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd BDR
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com